Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sinusitis | 23 | 2017 | 432 | 5.070 |
Why?
|
| Rhinitis | 19 | 2017 | 383 | 4.360 |
Why?
|
| Nasal Polyps | 17 | 2018 | 184 | 4.270 |
Why?
|
| Paranasal Sinuses | 10 | 2017 | 165 | 3.080 |
Why?
|
| Dendritic Cells | 6 | 2017 | 201 | 2.030 |
Why?
|
| Vitamin D Deficiency | 7 | 2017 | 292 | 1.990 |
Why?
|
| Cholecalciferol | 7 | 2017 | 143 | 1.460 |
Why?
|
| Nasal Mucosa | 8 | 2018 | 68 | 1.360 |
Why?
|
| Chronic Disease | 20 | 2018 | 1330 | 1.290 |
Why?
|
| Rhinitis, Allergic, Perennial | 3 | 2014 | 43 | 1.180 |
Why?
|
| Fibroblasts | 4 | 2016 | 902 | 1.140 |
Why?
|
| Vitamins | 3 | 2017 | 134 | 1.060 |
Why?
|
| Smoke | 2 | 2017 | 46 | 1.010 |
Why?
|
| T-Lymphocytes | 6 | 2017 | 597 | 0.980 |
Why?
|
| Tobacco | 2 | 2017 | 161 | 0.970 |
Why?
|
| Epithelial Cells | 8 | 2018 | 431 | 0.960 |
Why?
|
| Endothelial Cells | 4 | 2010 | 384 | 0.880 |
Why?
|
| Tobacco Smoke Pollution | 4 | 2017 | 127 | 0.840 |
Why?
|
| Carcinoma, Lewis Lung | 3 | 2010 | 20 | 0.780 |
Why?
|
| Mycoses | 2 | 2012 | 60 | 0.760 |
Why?
|
| Calcitriol | 3 | 2017 | 106 | 0.720 |
Why?
|
| Perforin | 2 | 2017 | 12 | 0.690 |
Why?
|
| Granzymes | 2 | 2017 | 19 | 0.690 |
Why?
|
| Macrophages | 5 | 2014 | 647 | 0.650 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 2 | 2015 | 21 | 0.650 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2010 | 219 | 0.620 |
Why?
|
| Respiratory Mucosa | 2 | 2014 | 52 | 0.570 |
Why?
|
| Vitamin D | 3 | 2017 | 516 | 0.560 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2015 | 48 | 0.490 |
Why?
|
| Respiratory Tract Diseases | 1 | 2015 | 43 | 0.490 |
Why?
|
| Middle Aged | 17 | 2017 | 21147 | 0.460 |
Why?
|
| Cells, Cultured | 8 | 2017 | 2673 | 0.460 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2013 | 41 | 0.460 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2013 | 45 | 0.450 |
Why?
|
| Eosinophilia | 1 | 2014 | 47 | 0.450 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2013 | 52 | 0.450 |
Why?
|
| Female | 23 | 2017 | 38074 | 0.440 |
Why?
|
| Case-Control Studies | 5 | 2015 | 1553 | 0.430 |
Why?
|
| Quality of Life | 3 | 2015 | 1515 | 0.430 |
Why?
|
| Male | 22 | 2017 | 37321 | 0.410 |
Why?
|
| Dinoprostone | 2 | 2010 | 110 | 0.410 |
Why?
|
| Humans | 31 | 2018 | 68618 | 0.390 |
Why?
|
| Cytokines | 5 | 2017 | 866 | 0.390 |
Why?
|
| Aged | 10 | 2017 | 14862 | 0.380 |
Why?
|
| Adult | 15 | 2017 | 21403 | 0.380 |
Why?
|
| Aspergillosis | 1 | 2011 | 20 | 0.380 |
Why?
|
| Th2 Cells | 1 | 2011 | 48 | 0.380 |
Why?
|
| B-Lymphocytes | 1 | 2013 | 329 | 0.380 |
Why?
|
| Fungi | 1 | 2011 | 27 | 0.380 |
Why?
|
| Lung Neoplasms | 2 | 2010 | 1173 | 0.380 |
Why?
|
| Th1 Cells | 1 | 2011 | 101 | 0.370 |
Why?
|
| Chemokines | 1 | 2011 | 119 | 0.360 |
Why?
|
| Tumor Escape | 1 | 2010 | 37 | 0.350 |
Why?
|
| Antigens, Fungal | 3 | 2015 | 19 | 0.340 |
Why?
|
| Immune Tolerance | 1 | 2010 | 114 | 0.340 |
Why?
|
| Interferon-gamma | 4 | 2011 | 241 | 0.330 |
Why?
|
| Killer Cells, Natural | 3 | 2017 | 94 | 0.310 |
Why?
|
| Aspergillus fumigatus | 4 | 2018 | 27 | 0.300 |
Why?
|
| Endoscopy | 3 | 2015 | 464 | 0.290 |
Why?
|
| Mouth Neoplasms | 1 | 2009 | 206 | 0.280 |
Why?
|
| Immunohistochemistry | 3 | 2014 | 1174 | 0.260 |
Why?
|
| Calcifediol | 2 | 2017 | 70 | 0.260 |
Why?
|
| Biomarkers | 4 | 2015 | 1593 | 0.250 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2009 | 629 | 0.230 |
Why?
|
| Adolescent | 5 | 2015 | 8912 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 8 | 2017 | 2791 | 0.200 |
Why?
|
| Up-Regulation | 2 | 2017 | 682 | 0.200 |
Why?
|
| Inflammation | 3 | 2018 | 1030 | 0.200 |
Why?
|
| Antigens, CD | 2 | 2014 | 230 | 0.190 |
Why?
|
| Disease Progression | 2 | 2015 | 1038 | 0.190 |
Why?
|
| Young Adult | 4 | 2017 | 5717 | 0.180 |
Why?
|
| Cell Differentiation | 2 | 2017 | 1034 | 0.180 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 1293 | 0.170 |
Why?
|
| Cell Proliferation | 3 | 2016 | 1174 | 0.170 |
Why?
|
| Mice | 10 | 2018 | 8474 | 0.170 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2017 | 199 | 0.170 |
Why?
|
| Rhinosporidiosis | 1 | 2018 | 7 | 0.160 |
Why?
|
| Ethmoid Bone | 1 | 2018 | 18 | 0.160 |
Why?
|
| Cell Line | 3 | 2018 | 1752 | 0.150 |
Why?
|
| Animals | 11 | 2018 | 20881 | 0.150 |
Why?
|
| Receptors, Complement | 1 | 2018 | 58 | 0.150 |
Why?
|
| Lymphocyte Activation | 2 | 2010 | 397 | 0.150 |
Why?
|
| Rhinitis, Allergic | 1 | 2017 | 22 | 0.150 |
Why?
|
| Mammary Glands, Human | 1 | 2017 | 33 | 0.150 |
Why?
|
| Antigens | 1 | 2017 | 90 | 0.150 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2017 | 65 | 0.140 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2017 | 51 | 0.140 |
Why?
|
| Monocytes | 1 | 2017 | 210 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2018 | 2324 | 0.130 |
Why?
|
| S100 Calcium-Binding Protein A4 | 1 | 2015 | 15 | 0.130 |
Why?
|
| Milk, Human | 1 | 2017 | 147 | 0.130 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 373 | 0.130 |
Why?
|
| Alternaria | 1 | 2015 | 4 | 0.130 |
Why?
|
| Cell Separation | 1 | 2015 | 132 | 0.130 |
Why?
|
| Calcium-Binding Proteins | 1 | 2015 | 114 | 0.130 |
Why?
|
| Health Status Indicators | 1 | 2015 | 117 | 0.130 |
Why?
|
| Chemokine CCL5 | 1 | 2015 | 23 | 0.120 |
Why?
|
| Mucus | 1 | 2015 | 33 | 0.120 |
Why?
|
| Child | 3 | 2015 | 6405 | 0.120 |
Why?
|
| Olfaction Disorders | 1 | 2016 | 100 | 0.120 |
Why?
|
| Chemokine CCL2 | 1 | 2015 | 101 | 0.120 |
Why?
|
| Cell Movement | 1 | 2017 | 630 | 0.120 |
Why?
|
| Superoxide Dismutase | 1 | 2015 | 149 | 0.120 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2014 | 30 | 0.120 |
Why?
|
| Complex Mixtures | 1 | 2014 | 14 | 0.120 |
Why?
|
| Hair | 1 | 2014 | 46 | 0.120 |
Why?
|
| Primary Cell Culture | 1 | 2014 | 56 | 0.120 |
Why?
|
| Cell Transplantation | 1 | 2004 | 22 | 0.120 |
Why?
|
| Allergens | 1 | 2014 | 54 | 0.110 |
Why?
|
| Plasma Cells | 1 | 2013 | 19 | 0.110 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2013 | 25 | 0.110 |
Why?
|
| Spleen | 1 | 2004 | 301 | 0.110 |
Why?
|
| Cell Communication | 1 | 2013 | 116 | 0.110 |
Why?
|
| Culture Media, Conditioned | 2 | 2010 | 78 | 0.110 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 1851 | 0.110 |
Why?
|
| Biopsy | 2 | 2013 | 540 | 0.110 |
Why?
|
| Phagocytosis | 2 | 2010 | 65 | 0.110 |
Why?
|
| Risk | 1 | 2014 | 563 | 0.100 |
Why?
|
| Retrospective Studies | 3 | 2014 | 7277 | 0.100 |
Why?
|
| Aspirin | 1 | 2014 | 295 | 0.100 |
Why?
|
| Flow Cytometry | 1 | 2013 | 489 | 0.100 |
Why?
|
| Graft vs Host Disease | 1 | 2004 | 163 | 0.100 |
Why?
|
| Interleukin-5 | 1 | 2011 | 14 | 0.100 |
Why?
|
| B7-2 Antigen | 1 | 2011 | 23 | 0.100 |
Why?
|
| B7-1 Antigen | 1 | 2011 | 20 | 0.100 |
Why?
|
| Th1-Th2 Balance | 1 | 2011 | 10 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2004 | 626 | 0.090 |
Why?
|
| Blood Circulation | 1 | 2011 | 18 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 498 | 0.090 |
Why?
|
| Nicotine | 1 | 2014 | 350 | 0.090 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 2279 | 0.090 |
Why?
|
| Bone Remodeling | 1 | 2011 | 45 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 507 | 0.090 |
Why?
|
| Reactive Oxygen Species | 1 | 2013 | 499 | 0.090 |
Why?
|
| Cell Count | 1 | 2011 | 248 | 0.090 |
Why?
|
| CD4 Antigens | 1 | 2010 | 42 | 0.090 |
Why?
|
| Antibodies, Neutralizing | 1 | 2010 | 46 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2012 | 1040 | 0.090 |
Why?
|
| Prospective Studies | 2 | 2014 | 3705 | 0.090 |
Why?
|
| Indomethacin | 1 | 2010 | 107 | 0.090 |
Why?
|
| Pyrroles | 1 | 2010 | 83 | 0.080 |
Why?
|
| Interleukin-2 | 1 | 2010 | 133 | 0.080 |
Why?
|
| Indoles | 1 | 2010 | 146 | 0.080 |
Why?
|
| Microcirculation | 1 | 2009 | 77 | 0.080 |
Why?
|
| Age Factors | 1 | 2014 | 1864 | 0.080 |
Why?
|
| Complement Activation | 1 | 2010 | 145 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 3 | 2018 | 532 | 0.080 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2008 | 66 | 0.080 |
Why?
|
| Housing, Animal | 1 | 2008 | 16 | 0.080 |
Why?
|
| Phenotype | 1 | 2011 | 947 | 0.080 |
Why?
|
| Corticosterone | 1 | 2008 | 51 | 0.080 |
Why?
|
| Immune System | 1 | 2008 | 63 | 0.080 |
Why?
|
| Down-Regulation | 1 | 2009 | 447 | 0.070 |
Why?
|
| Surveys and Questionnaires | 1 | 2015 | 2800 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 331 | 0.070 |
Why?
|
| Weight Gain | 1 | 2008 | 135 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 742 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 371 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2014 | 1615 | 0.070 |
Why?
|
| Child, Preschool | 1 | 2012 | 3187 | 0.060 |
Why?
|
| Behavior, Animal | 1 | 2008 | 470 | 0.060 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2004 | 22 | 0.060 |
Why?
|
| Radiation Tolerance | 1 | 2004 | 30 | 0.060 |
Why?
|
| Complement C3 | 2 | 2018 | 101 | 0.060 |
Why?
|
| Intestine, Small | 1 | 2004 | 89 | 0.060 |
Why?
|
| RNA, Messenger | 2 | 2017 | 1664 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2004 | 432 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 2008 | 824 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 2550 | 0.050 |
Why?
|
| Whole-Body Irradiation | 2 | 2004 | 52 | 0.040 |
Why?
|
| Dissection | 1 | 2018 | 29 | 0.040 |
Why?
|
| Nasal Lavage | 1 | 2017 | 6 | 0.040 |
Why?
|
| Blood Cell Count | 1 | 2017 | 35 | 0.040 |
Why?
|
| Cadaver | 1 | 2018 | 136 | 0.040 |
Why?
|
| Proteome | 1 | 2018 | 87 | 0.040 |
Why?
|
| Eosinophils | 1 | 2017 | 60 | 0.040 |
Why?
|
| Skull Base | 1 | 2018 | 72 | 0.040 |
Why?
|
| Bone Density | 1 | 2018 | 159 | 0.040 |
Why?
|
| Vitamin D3 24-Hydroxylase | 1 | 2017 | 24 | 0.040 |
Why?
|
| Trachea | 1 | 2017 | 48 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2017 | 228 | 0.040 |
Why?
|
| Neutrophils | 1 | 2017 | 204 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2015 | 71 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2017 | 332 | 0.030 |
Why?
|
| Visual Analog Scale | 1 | 2014 | 8 | 0.030 |
Why?
|
| Interleukins | 1 | 2014 | 79 | 0.030 |
Why?
|
| CD3 Complex | 1 | 2004 | 35 | 0.030 |
Why?
|
| Diet | 1 | 2017 | 514 | 0.030 |
Why?
|
| Transplantation Conditioning | 1 | 2004 | 34 | 0.030 |
Why?
|
| Antigens, Differentiation | 1 | 2004 | 49 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2014 | 381 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2004 | 242 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2015 | 330 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 2077 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2014 | 1738 | 0.020 |
Why?
|
| Complement Factor B | 1 | 2010 | 19 | 0.020 |
Why?
|
| Prevalence | 1 | 2014 | 1619 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 189 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2018 | 2689 | 0.020 |
Why?
|
| Population Control | 1 | 2008 | 3 | 0.020 |
Why?
|
| Population Density | 1 | 2008 | 18 | 0.020 |
Why?
|
| Social Isolation | 1 | 2008 | 40 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2008 | 852 | 0.020 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2004 | 12 | 0.020 |
Why?
|
| Smoking | 1 | 2010 | 1452 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 1745 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2004 | 1692 | 0.010 |
Why?
|